A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 134 participants.
Also called NCT05961787
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 134 participants
- Registry
-
NCT05961787
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05961787. Randomized; no masking; primary purpose treatment. Start 2022-12-30 (actual); primary completion 2025-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)
- Acronym
- LARGE-ONE
- Condition
- Coronary Artery Disease
- Intervention (Device)
- SeQuent® Please drug coating balloon(DCB),Firehawk family drug eluting stent(DES)
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
Record details
- Record id
cardio:ct-nct05961787- Content hash
8a27ea8a7d5faf45c75d5b869b3dfae9b1484ed37c72f392c384a424ea00ace5